{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:08:12Z","timestamp":1794845292200,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360503"],"award-info":[{"award-number":["82360503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bingtuan Science and Technology Program","award":["2022ZD002"],"award-info":[{"award-number":["2022ZD002"]}]},{"name":"Tianshan Talent Science and Technology Innovation Team Project","award":["2023TSYCTD0020"],"award-info":[{"award-number":["2023TSYCTD0020"]}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2020-PT330-003"],"award-info":[{"award-number":["2020-PT330-003"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triggering receptor expressed on myeloid cells 2 (TREM2), a surface receptor predominantly expressed on myeloid cells, is a major hub gene in pathology-induced immune signaling. However, its function in hepatocellular carcinoma (HCC) remains controversial. This study aimed to evaluate the role of TREM2 in the tumor microenvironment in the context of HCC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      HCC was experimentally induced in wild-type (WT) and\n                      <jats:italic>Trem2<\/jats:italic>\n                      -deficient (\n                      <jats:italic>Trem2<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ) mice, and clinical sample analysis and in vitro studies on macrophages were conducted. HCC cells were treated with conditioned medium from WT or\n                      <jats:italic>Trem2<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      macrophages, and their malignant phenotypes and underlying mechanisms were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>TREM2<\/jats:italic>\n                      deficiency reduced liver tumor burden in orthotopic and subcutaneous HCC models by altering CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell infiltration.\n                      <jats:italic>Trem2<\/jats:italic>\n                      -deficient macrophages presented increased chemokine secretion. TGF-\u03b21 was found to be positively correlated with TREM2 expression in HCC, and TGF-\u03b2 blockade reversed TREM2 induction. On the other hand, TREM2\n                      <jats:sup>+<\/jats:sup>\n                      macrophages were found to be associated with glycolysis and PKM2 expression in HCC cells; this association may be related to the secretion of IL-1\u03b2, which enhances the malignant phenotypes of HCC cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These results reveal that TREM2\n                      <jats:sup>+<\/jats:sup>\n                      macrophages play a driving role in HCC progression by suppressing CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell infiltration and promoting tumor cell glycolysis, providing a new therapeutic target for HCC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03287-w","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T23:16:48Z","timestamp":1737415008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["TREM2 promotes the formation of a tumor-supportive microenvironment in hepatocellular carcinoma"],"prefix":"10.1186","volume":"44","author":[{"given":"Hanrui","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiya","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"1","key":"3287_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3287_CR2","doi-asserted-by":"crossref","unstructured":"Chakraborty E, Sarkar D. Emerging therapies for Hepatocellular Carcinoma (HCC). Cancers (Basel). 2022;14(11).","DOI":"10.3390\/cancers14112798"},{"issue":"11","key":"3287_CR3","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.3390\/curroncol30110711","volume":"30","author":"F Bicer","year":"2023","unstructured":"Bicer F, Kure C, Ozluk AA, El-Rayes BF, Akce M. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC). Curr Oncol. 2023;30(11):9789\u2013812.","journal-title":"Curr Oncol"},{"key":"3287_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/JHC.S311496","volume":"8","author":"C Monge","year":"2021","unstructured":"Monge C, Xie C, Steinberg SM, Greten TF. Clinical indicators for long-term survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:507\u201312.","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"3287_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I. The Physiology, Pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 2020;181(6):1207\u201317.","journal-title":"Cell"},{"issue":"1","key":"3287_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):66.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"3287_CR7","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","volume":"122","author":"C Cochain","year":"2018","unstructured":"Cochain C, Vafadarnejad E, Arampatzi P, Pelisek J, Winkels H, Ley K, et al. Single-cell RNA-Seq reveals the Transcriptional Landscape and Heterogeneity of Aortic macrophages in Murine atherosclerosis. Circ Res. 2018;122(12):1661\u201374.","journal-title":"Circ Res"},{"issue":"4","key":"3287_CR8","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","volume":"177","author":"JA Hamerman","year":"2006","unstructured":"Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol. 2006;177(4):2051\u20135.","journal-title":"J Immunol"},{"issue":"3","key":"3287_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gutjnl-2017-314107","volume":"68","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, Esparza-Baquer A, Oakley F, Labiano I, Korosec A, Jais A, et al. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage. Gut. 2019;68(3):533\u201346.","journal-title":"Gut"},{"issue":"11","key":"3287_CR10","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.7150\/jca.55077","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Hou X, Yuan S, Zhang Y, Yuan W, Liu X, et al. High expression of TREM2 promotes EMT via the PI3K\/AKT pathway in gastric cancer: bioinformatics analysis and experimental verification. J Cancer. 2021;12(11):3277\u201390.","journal-title":"J Cancer"},{"key":"3287_CR11","doi-asserted-by":"publisher","first-page":"1089266","DOI":"10.3389\/fimmu.2022.1089266","volume":"13","author":"M Yu","year":"2022","unstructured":"Yu M, Chang Y, Zhai Y, Pang B, Wang P, Li G, et al. TREM2 is associated with tumor immunity and implies poor prognosis in glioma. Front Immunol. 2022;13:1089266.","journal-title":"Front Immunol"},{"issue":"11","key":"3287_CR12","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184(11):2988\u2013e300516.","journal-title":"Cell"},{"key":"3287_CR13","doi-asserted-by":"publisher","first-page":"646523","DOI":"10.3389\/fimmu.2021.646523","volume":"12","author":"X Cheng","year":"2021","unstructured":"Cheng X, Wang X, Nie K, Cheng L, Zhang Z, Hu Y, et al. Systematic Pan-cancer Analysis identifies TREM2 as an immunological and prognostic biomarker. Front Immunol. 2021;12:646523.","journal-title":"Front Immunol"},{"key":"3287_CR14","doi-asserted-by":"publisher","first-page":"848367","DOI":"10.3389\/fimmu.2022.848367","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Wang M, Guo H, Hou J, Zhang Y, Li M, et al. Integrated Analysis highlights the immunosuppressive role of TREM2(+) macrophages in Hepatocellular Carcinoma. Front Immunol. 2022;13:848367.","journal-title":"Front Immunol"},{"issue":"2","key":"3287_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41389-018-0115-x","volume":"8","author":"W Tang","year":"2019","unstructured":"Tang W, Lv B, Yang B, Chen Y, Yuan F, Ma L, et al. TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K\/Akt\/beta-catenin pathway. Oncogenesis. 2019;8(2):9.","journal-title":"Oncogenesis"},{"issue":"7","key":"3287_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/gutjnl-2019-319227","volume":"70","author":"A Esparza-Baquer","year":"2021","unstructured":"Esparza-Baquer A, Labiano I, Sharif O, Agirre-Lizaso A, Oakley F, Rodrigues PM, et al. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms. Gut. 2021;70(7):1345\u201361.","journal-title":"Gut"},{"issue":"5","key":"3287_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/ol.2020.12128","volume":"20","author":"K Fu","year":"2020","unstructured":"Fu K, Yang X, Wu H, Gong J, Li X. Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma. Oncol Lett. 2020;20(5):265.","journal-title":"Oncol Lett"},{"key":"3287_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.026","volume":"72","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang W, Li P, Wang X, Ni K. High TREM2 expression correlates with poor prognosis in gastric cancer. Hum Pathol. 2018;72:91\u20139.","journal-title":"Hum Pathol"},{"key":"3287_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"3287_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"3287_CR21","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.drup.2023.100976","volume":"69","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou L, Ji N, Sun C, Sun L, Sun J, et al. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. Drug Resist Updat. 2023;69:100976.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"3287_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s42255-019-0156-2","volume":"2","author":"K Ohshima","year":"2020","unstructured":"Ohshima K, Nojima S, Tahara S, Kurashige M, Kawasaki K, Hori Y, et al. Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine. Nat Metab. 2020;2(1):81\u201396.","journal-title":"Nat Metab"},{"issue":"6657","key":"3287_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill R, Wirapati P, Messemaker M, Roh W, Zitti B, Duval F, et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science. 2023;381(6657):515\u201324.","journal-title":"Science"},{"issue":"9","key":"3287_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","volume":"34","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen Z, Kuang H, Liu T, Zhu J, Zhou L, et al. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment. Cell Metab. 2022;34(9):1359\u201376. e7.","journal-title":"Cell Metab"},{"issue":"1","key":"3287_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39(1):126.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"3287_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.molcel.2020.05.004","volume":"78","author":"PP Hou","year":"2020","unstructured":"Hou PP, Luo LJ, Chen HZ, Chen QT, Bian XL, Wu SF, et al. Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the Tumor Microenvironment. Mol Cell. 2020;78(6):1192\u2013e20610.","journal-title":"Mol Cell"},{"issue":"4","key":"3287_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13402-018-0383-7","volume":"41","author":"G van Niekerk","year":"2018","unstructured":"van Niekerk G, Engelbrecht AM. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target. Cell Oncol (Dordr). 2018;41(4):343\u201351.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"3287_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"AL Cheng","year":"2022","unstructured":"Cheng AL, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus Bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76(4):862\u201373.","journal-title":"J Hepatol"},{"issue":"11","key":"3287_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Villanueva A, Korangy F, Ruf B, Yarchoan M, Ma L, et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nat Rev Clin Oncol. 2023;20(11):780\u201398.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3287_CR30","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1038\/s41598-022-08225-w","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang X, Zhou L, Gao X, Wu X, Chen X, et al. Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma. Sci Rep. 2022;12(1):4259.","journal-title":"Sci Rep"},{"issue":"4","key":"3287_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora M, Esaulova E, Vermi W, Hou J, Chen Y, Luo J, et al. TREM2 modulation remodels the Tumor Myeloid Landscape enhancing Anti-PD-1 immunotherapy. Cell. 2020;182(4):886\u2013e90017.","journal-title":"Cell"},{"issue":"1","key":"3287_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","volume":"79","author":"J Tan","year":"2023","unstructured":"Tan J, Fan W, Liu T, Zhu B, Liu Y, Wang S, et al. TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. J Hepatol. 2023;79(1):126\u201340.","journal-title":"J Hepatol"},{"issue":"3","key":"3287_CR33","doi-asserted-by":"publisher","first-page":"109844","DOI":"10.1016\/j.celrep.2021.109844","volume":"37","author":"M Binnewies","year":"2021","unstructured":"Binnewies M, Pollack JL, Rudolph J, Dash S, Abushawish M, Lee T, et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep. 2021;37(3):109844.","journal-title":"Cell Rep"},{"issue":"4","key":"3287_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179(4):829\u201345. e20.","journal-title":"Cell"},{"issue":"5","key":"3287_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","volume":"24","author":"MD Park","year":"2023","unstructured":"Park MD, Reyes-Torres I, LeBerichel J, Hamon P, LaMarche NM, Hegde S, et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol. 2023;24(5):792\u2013801.","journal-title":"Nat Immunol"},{"issue":"6","key":"3287_CR36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ccell.2024.05.001","volume":"42","author":"J Zhong","year":"2024","unstructured":"Zhong J, Xing X, Gao Y, Pei L, Lu C, Sun H, et al. Distinct roles of TREM2 in central nervous system cancers and peripheral cancers. Cancer Cell. 2024;42(6):968\u201384. e9.","journal-title":"Cancer Cell"},{"issue":"5","key":"3287_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/neuonc\/noad214","volume":"26","author":"J Zheng","year":"2024","unstructured":"Zheng J, Wang L, Zhao S, Zhang W, Chang Y, Bosco DB, et al. TREM2 mediates MHCII-associated CD4\u2009+\u2009T-cell response against gliomas. Neuro Oncol. 2024;26(5):811\u201325.","journal-title":"Neuro Oncol"},{"issue":"82","key":"3287_CR38","doi-asserted-by":"publisher","first-page":"eadd8945","DOI":"10.1126\/sciimmunol.add8945","volume":"8","author":"T Fabre","year":"2023","unstructured":"Fabre T, Barron AMS, Christensen SM, Asano S, Bound K, Lech MP, et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci Immunol. 2023;8(82):eadd8945.","journal-title":"Sci Immunol"},{"key":"3287_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cytogfr.2018.11.001","volume":"44","author":"Q Tan","year":"2018","unstructured":"Tan Q, Huang Q, Ma YL, Mao K, Yang G, Luo P, et al. Potential roles of IL-1 subfamily members in glycolysis in disease. Cytokine Growth Factor Rev. 2018;44:18\u201327.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"3287_CR40","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/hep.29681","volume":"67","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang Q, Lou Y, Fu Q, Chen Q, Wei T, et al. Hypoxia-inducible factor-1alpha\/interleukin-1beta signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment. Hepatology. 2018;67(5):1872\u201389.","journal-title":"Hepatology"},{"issue":"7986","key":"3287_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni N, La Terza F, Vittoria FM, Barbiera G, Mezzanzanica L, Cuzzola V, et al. IL-1beta(+) macrophages fuel pathogenic inflammation in pancreatic cancer. Nature. 2023;623(7986):415\u201322.","journal-title":"Nature"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03287-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T23:16:58Z","timestamp":1737415018000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03287-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3287"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03287-w","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Animal Experimental Ethical Inspection (A2023-041-01) and the Science and Technology Ethical Committee (KJ2023-044-01) of the First Affiliated Hospital, Shihezi University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}